March 21, 2017
Webinar
As courts apply the Supreme Court’s direction on willful infringement, U.S. companies have guideposts to look to on the bounds in which they can operate. For in-house counsel with a budget, obtaining an opinion letter for protection can be a challenge. Additionally, medical device companies often face issues relating to patent exhaustion and whether medical devices can be limited to a single use. With the state of law in flux and the Supreme Court’s consideration of those issues to be heard, how should your company operate in the interim, and how might your actions under changing laws factor into the willfulness analysis?
Please join our panelists as they answer these questions and discuss the following topics:
Moderator:
J. Michael Jakes
Kathleen A. Daley
Justin A. Hendrix
Tuesday, March 21, 2017
10:00 - 11:00 a.m. PDT
1:00 - 2:00 p.m. EDT
Scheduling Conflict? Finnegan records all hosted webinars. To view the recorded program, simply register for the webinar and you will receive an access link shortly after the live program is complete.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
INCONTESTABLE® Blog
April 19, 2024
Hybrid Seminar
Pandora’s Pixels: Can Privacy and Choice Survive in our Generative AI World?
April 11, 2024
Richmond
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.